跳至主要内容
临床试验/ACTRN12617000492358
ACTRN12617000492358已完成未知

Targeted combination therapy with Mandibular Advancement Device (MAD) and Continuous Positive Airway Pressure (CPAP) : Physiological mechanistic studies to inform treatment for obstructive sleep apnoea (OSA)

Oventus Medical Ltd0 个研究点目标入组 47 人开始时间: 2017年4月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Otherwise healthy adult men and women with OSA
  • 2. Currently using Oventus MAD as their primary treatment
  • 3. Participants who are willing and able to give written informed consent and willingness to participate and comply with the study procedures.

排除标准

  • 1. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
  • 2. Patients with any other medical condition which may interfere in the evaluation of the study.
  • 3. People with intellectual or mental impairment or any condition that may interfere with their ability to consent for themselves.
  • 4. Patients with a previous history of addiction to alcohol or drugs.
  • 5. Patients taking medications known to affect sleep or pharyngeal muscle activity.
  • 6. Previous side effects or known allergies to the sleeping pill zopiclone.

研究者

相似试验